In CRS, type 2 immune responses are typically characterized by the production of cytokines such as interlukin (IL)‐ 4 (IL‐4), IL‐5, IL‐13, and IL‐10 by group 2 innate lymphoid cells (ILC2) and Th2 cells. This evidence concerns the gene IL13 and congenital rubella syndrome.